This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This rapid processing not only enhances throughput, but will also allow pharmaceuticalcompanies to respond more swiftly to market demands. Can pharma tariffs “Make America Manufacture Again”?
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceuticalcompanies, the insurance companies, all make money by keeping us sick. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
Large pharmaceuticalcompanies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. Can pharma tariffs “Make America Manufacture Again”? ASOs accounted for more than half ($3.54
By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceuticalcompanies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Can pharma tariffs “Make America Manufacture Again”? Stay proactive with real-time data and expert analysis.
Other countries from outside the EU and international organisations such as pharmaceuticalcompanies will be able to apply to join HealthData@EU for secondary use in March 2034. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.
GMP/GLP and PPE training are applied to all employees, contractors and casual staff working in a GMP environment, including manufacturing, packaging, labelling, distribution, QA, QC, development, validation, engineering, IT staff and anyone whose activities could affect product quality. Related Posts You may like to read these related posts.
Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics).
Vaccine R&D stagnation likely Although ACIP recommendations are separate from the US Food and Drug Administration (FDA)’s approvals, national immunisation recommendation provides a key pillar on which to guide pipeline development for a pharmaceuticalcompany. Can pharma tariffs “Make America Manufacture Again”?
He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceuticalcompanies. Can pharma tariffs “Make America Manufacture Again”? The health secretary pointed to historical evidence for this, including an investigation from over 20 years ago.
It feels like in the US, pharmaceuticalcompanies are capitalising on people’s frustration and desperation to lose weight.” Novo Nordisk took a different route with Hims & Hers – the drugmaker partnered with the telehealth company to offer Wegovy via a bundled membership package in April 2025.
More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceuticalcompanies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US. Can pharma tariffs “Make America Manufacture Again”?
Katarina Zahedi, pharma analyst at GlobalData, comments: “These investments reflect a growing trend among pharmaceuticalcompanies to bolster domestic operations in response to geopolitical pressures and potential tariffs on imported pharmaceuticals.” Can pharma tariffs “Make America Manufacture Again”?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content